![Logo for Basilea Pharmaceutica AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb45e5-2023-02-13-02-38-59.png&w=256&q=100)
Basilea Pharmaceutica Investor Relations Material
Latest events
![Logo for Basilea Pharmaceutica AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb45e5-2023-02-13-02-38-59.png&w=128&q=100)
H2 2023
Basilea Pharmaceutica
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Basilea Pharmaceutica AG
Access all reports
Basilea Pharmaceutica Ltd. operates as a commercial stage biopharmaceutical company in the United States and internationally. The company focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives, and various supportive care products for cancer patients undergoing chemotherapy treatment or for those being treated with antibiotics. It also develops ceragenin technology to treat hospital acquired bacterial infections; and CRAPOMICIN, a novel, semi-synthetic lipoglycopeptide antibiotic candidate, which is in clinical development for complicated skin and soft tissue infections, including acute bacterial skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus bacteria, as well as ventilator associated pneumonia caused by Gram negative bacteria.
Key slides for Basilea Pharmaceutica AG
![2024 Guidance - 20 %](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fbasilea-pharmaceutica-ag-h2-2023-3a978559daa69584%2F11.png&w=3840&q=75)
![Logo for Basilea Pharmaceutica AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb45e5-2023-02-13-02-38-59.png&w=128&q=100)
H2 2023
Basilea Pharmaceutica AG
![Strong FY23 results](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fbasilea-pharmaceutica-ag-h2-2023-3a978559daa69584%2F8.png&w=3840&q=75)
![Logo for Basilea Pharmaceutica AG](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fb45e5-2023-02-13-02-38-59.png&w=128&q=100)
H2 2023
Basilea Pharmaceutica AG
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
BSLN
Country
🇨🇭 Switzerland